RXi Pharmaceuticals Corp (OTC:RXII), A.P. Pharma, Inc. (OTC:APPA) and Terra Tech Corp (OTC: TRTC) have been added to our watch list.
RXi Pharmaceuticals Corp (OTC:RXII) is a biotechnology development-stage company. It focused on discovering, developing therapies addressing medical needs using RNA interference. It’s therapeutic platform consists of two main components including RNAi Compounds (rxRNA) and Advanced Delivery Technologies. rxRNA compounds include rxRNAori, rxRNAsolo and sd-rxRNA, or self-delivering RNA. On April 26, 2012, it has successfully completed the spin-off transaction from Galena Biopharma, Inc.
For our complete article on RXII please go here: http://tinyurl.com/OTCmagic-RXII
A.P. Pharma, Inc. (OTC:APPA) deals in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. This technology consists of bioerodible polymers designed to release drugs over a defined period of time. This technology is applicable to a range of therapeutic areas, including pain management, prevention of nausea and control of inflammation diseases. It was previously known as Advanced Polymer Systems Inc but changed its name to A.P. Pharma, Inc. in May 2001.
For our complete article on APPA please go here: http://tinyurl.com/OTCmagic-APPA
Terra Tech Corp (OTC: TRTC) deals in the manufacturing, marketing, and sale of horticulture equipment at different locations in United States. It works closely with horticulturists, engineers, and scientists for the development and manufacturing of proprietary products for the hydroponic industry. It delivers its products to horticulture enthusiasts, local urban farmers and green house growers through a network of specialty retailers in the U.S. The company was established in 2010 and is settled in Irvine, California.
For our complete article on TRTC please go here: http://tinyurl.com/OTCmagic-TRTC
OTCMAGIC is a newsletter that reports on developments in the world of penny stocks. OTCMagic is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit OTCMagic.com website, for complete risks and disclosures.
Subscribe Here: http://www.otcmagic.com/
Contact Info:
OTCMagic
info@otcmagic.com